Drug Experimentation

Drug Experimentation

Introduction

To market a new drug, the healthcare professionals are required to first test it for a long time in animals and humans in clinical trials. The clinical trial is an extraordinary means to evaluate the effectiveness of a medicine. There are risks involved but these trials ultimately provides base to decide whether to make the drug available to the public. However, many are not able to take the decision whether or not to consent to testing, especially those living in developing countries who often participate in these protocols (Monagle & Thomasma, 2004).

It has been debating that it is not ethical about doctors to experiments new drugs on homeless people or poor people in clinical trials. However, this practice is necessary to launch new medicines in market for the development of healthcare services and industry. It brings in good results on the whole. In this paper we will discuss that it is justified for doctors to experiments new drugs on homeless people in order to launch the medicine in market with respect to ethical context.

Discussion

The relevance of drug experimentation of doctors on people in clinical trials cannot be overstated. In the evaluation of this practice we have to take the position to make retrospective moral judgment. It is the fact that the therapeutic effect can be tested only on humans, so that a clinical trial on patients is essential to test the absence of adverse effects, in order to address the risks associated with the use of the drug. Moreover, only clinical trials can identify the benefits achievable with the use of the medicines and the potential side effects can be identified. The phenomenon also from the legal point of view is presented readable by multiple angles, the variety of issues that it involves the impact of technological developments, for the variety of norms that regulate it.

Regulations to Obtain Informed Consent

There are several regulations for the protection of people who take part in clinical trials for medicines. These regulations protect the vulnerable subjects for clinical trials. However, these regulations on clinical trials on medicinal products for human use is in fact a proposal to boost clinical research, but at the same time these regulations ensures the highest level of protection for trial participants, as well as the reliability of the acquired data. In the first place the voluntary nature of choice: voluntary participation in research projects for the good of ...